If the market feels shaky right now, that is not your imagination.
Practice owners are watching war headlines, feeling higher costs at the pump, and seeing the stock market swing hard. They are hearing constant warnings about inflation, rates, and instability. The Federal Reserve said on March 18, 2026 that uncertainty around the economic outlook remains elevated. Developments in the Middle East are also uncertain for the U.S. economy.
Consumer sentiment is soft: the University of Michigan’s preliminary March 2026 index came in at 55.5, down from 56.6 in February. CPI was up 2.4% year over year in February 2026. At the same time, energy and markets have been swinging with the war. Reuters reported U.S. gasoline prices had climbed above $3.75 per gallon by March 17, the highest average since October 2023.
AP reported stocks and oil both moved sharply on fresh Iran war headlines and shifting de-escalation hopes.
That backdrop matters because medical aesthetics lives inside the real economy, not outside of it.
But uncertain times do not automatically eliminate demand in aesthetics. They make demand more selective. Buyers become more cautious, more value-conscious, and less forgiving of weak positioning, weak follow-up, and weak retention strategy. McKinsey’s 2025 beauty research found executives expect growth to become less price-driven while consumer scrutiny of perceived value rises, and 54% said uncertain consumer appetite or restricted spending is the biggest risk to future growth.
Why the pressure feels real
The pressure owners and clients feel right now is not abstract.
The war in the Middle East has been feeding energy volatility. Reuters reported Brent crude surged as high as roughly $110 before pulling back, and AP reported Brent later dropped to about $99.94 after temporary optimism around diplomacy, even as Iran denied talks. AP also reported the Dow jumped 631 points on March 23 as hopes of de-escalation briefly lifted markets, a reminder that this is a headline-driven environment with real financial whiplash.
That kind of environment changes how people think about discretionary spending. It does not mean they stop caring about their appearance, confidence, or maintenance. Instead, they pause longer and compare options harder.
Why medical aesthetics is under pressure, but not collapsing
The latest published structural benchmarks still show a meaningful industry, not a disappearing one.
AmSpa’s latest state-of-the-industry recap says the U.S. had 10,488 medical spas, average annual revenue was about $1.40 million, average visit value was $527, and the average practice saw 245 visits per month. AmSpa also reports that about 73% of visits come from repeat patients. On the broader aesthetics side, the American Society of Plastic Surgeons reported 28.24 million minimally invasive procedures in 2024, and AAFPRS said its 2025 annual survey points to a projected 19% increase in facial procedures, with patients increasingly favoring earlier, subtler, more strategic care.
So the real story is not that demand vanished.
The real story is that uncertain markets expose weak operators faster. Generic marketing and inconsistent follow-up become much more expensive when buyers get selective. Over-reliance on promotions and poor retention strategies are also more glaring.
How buyer behavior changes in uncertain times
A common misconception in medical aesthetics marketing during uncertain times is that uncertainty equates to lower interest. Often, it actually results in greater scrutiny from consumers.
Usually, it means higher scrutiny.
Clients who used to make quick decisions are now pausing to consider timing. New leads are comparing multiple providers before making bookings. Clients may request phased treatment plans rather than committing to everything at once. They still desire results but seek greater confidence before spending.
A returning client who used to say yes immediately now wants to think about timing. A new lead compares more providers before booking. A client asks whether a treatment plan can be phased instead of done all at once. Someone still wants the outcome but seeks more confidence before spending.
This manifests in practical ways:
In practical terms, that looks like this:
In practical terms, that looks like this:
A returning client who used to say yes immediately now wants to think about timing.
A new lead compares more providers before booking.
A client asks whether a treatment plan can be phased instead of done all at once.
Someone still wants the outcome, but wants more confidence before spending.
That is not dead demand. It is more selective demand.
And selective demand rewards practices that make value easier to understand.
What high-performing medical aesthetics practices do differently
Protect visibility instead of disappearing
High-performing practices do not panic and go quiet.
When buyers are nervous, visibility matters more, not less. If people are comparing harder and searching more carefully, disappearing from Google, local listings, educational content, and follow-up touchpoints is one of the worst moves a practice can make.
AmSpa’s March 2026 visibility guidance says Google Business Profile completeness, updated hours, service descriptions, photos, and website relevance all influence whether a clinic shows up when people search. It also notes that many buyers now begin with Google or AI-assisted search when choosing a provider.
Lean harder into high-intent demand
When buyers get cautious, high-intent demand becomes even more valuable.
That means focusing more on:
- local SEO
- treatment + location search visibility
- branded search protection
- treatment pages built around real concerns
- clearer trust signals
AmSpa’s December 2025 local SEO article says 72% of people who search locally end up visiting a business within five miles, and it notes that Google Business Profile visibility strongly shapes who even gets considered. That is especially relevant for medical spas and aesthetic practices competing in dense local markets.
Double down on retention
If repeat visits make up such a large share of medical spa revenue, retention is not a side strategy. It is a core growth strategy. AmSpa’s industry recap says about 73% of visits are repeat visits, which is exactly why experienced owners focus hard on rebooking, maintenance reminders, lifecycle messaging, and inactive-client reactivation when the market gets tight.
AmSpa’s client engagement guidance specifically recommends building what it calls a “loyalty ecosystem” that keeps clients connected before, during, and after visits instead of treating every appointment like a one-off transaction.
Increase accessibility without lowering price
Strong practices do not automatically slash pricing when confidence drops. This approach rarely improves medical aesthetics marketing in uncertain times.
Instead, they make treatment access easier without cheapening the brand.
That often means:
- financing
- phased treatment plans
- maintenance-first roadmaps
- membership perks
- credits or added value tied to longer-term relationships
AmSpa’s financing coverage says practices offering patient financing reported 27% higher average transaction value, 23% faster decision making, and 22% increased treatment volume. It also says nearly nine in ten respondents viewed financing as at least somewhat important to success, while 72% said it gave them a competitive advantage.
Build more predictable recurring revenue
When the outside environment is unstable, predictability becomes more valuable.
AmSpa’s demand-trends coverage says membership-based models are gaining traction because they create predictable revenue, improve retention, and convert one-time visitors into longer-term relationships. That is especially relevant in medical aesthetics, where consistency and maintenance matter more than one-off wins.
When the outside environment is unstable, predictability becomes more valuable. AmSpa’s demand-trends coverage indicates membership-based models are gaining traction. They create predictable revenue, improve retention, and convert one-time visitors into longer-term relationships.
Local SEO and Google capture
This is one of the strongest plays because it captures people already searching for help. In uncertain periods, high-intent search usually matters more than loose awareness traffic. AmSpa explicitly frames local SEO as a high-ROI path for getting found by ready-to-book clients.
Educational content
Not generic content. Better content.
Content that answers hesitation:
- what is worth doing now
- what can wait
- how to maintain results more intelligently
- how to think about treatment timing
- how to phase a plan without losing the long-term outcome
This matters because cautious buyers want clarity, not hype. McKinsey’s value-scrutiny finding supports that, and AmSpa’s recent visibility article reinforces that educational content now supports both search discovery and AI discovery.
Reactivation and lifecycle messaging
A cautious client often needs more touches, not necessarily a lower price.
That is why email and SMS can hold up well in uncertain markets when used for:
- maintenance reminders
- milestone follow-up
- inactive-client reactivation
- education around timing and value
- post-visit nurture
AmSpa’s engagement guidance recommends inactivity triggers, milestone campaigns, and loyalty-focused communication rather than relying only on constant new-client acquisition.
Review and trust building
When people compare harder, proof matters more.
That means stronger review generation, clearer practitioner positioning, more complete local profiles, and more visible trust signals. AmSpa’s March 2026 guidance directly ties discoverability to profile quality, service clarity, and relevance.
How to reduce churn without lowering price
This is where many practices make avoidable mistakes.
They assume uncertain markets require cheaper pricing.
Usually, they require better value architecture.
That can include:
- memberships with maintenance logic
- treatment roadmaps instead of isolated visits
- phased options instead of all-at-once pressure
- financing for larger-ticket acceptance
- perks, credits, or convenience upgrades instead of blunt discounting
- better post-treatment communication
- smarter rebooking systems
AmSpa’s engagement guidance supports loyalty ecosystems and retention mechanics, while its financing coverage shows flexibility can improve acceptance and average spend without lowering list prices.
The goal is not to become cheaper.
The goal is to become easier to say yes to.
AmSpa’s guidance stresses the importance of maintaining engagement through inactivity triggers and milestone campaigns, advocating for loyalty-focused communication instead of merely acquiring new clients.
Where MuseMD fits
AmSpa’s engagement guidance recommends inactivity triggers, milestone campaigns, and loyalty-focused communication. This is instead of relying solely on constant new-client acquisition.
This is exactly where MuseMD becomes relevant.
Uncertain markets reward practices that have better visibility into lead flow, better follow-up discipline, stronger retention systems, and a clearer connection between marketing effort and actual booked business.
That is the role MuseMD should play in this conversation.
Not fear-based software positioning. System-based resilience.
Final thought
The current moment is real.
War headlines are real.
Gas prices are real.
Market swings are real.
Consumer caution is real.
But that does not automatically mean medical aesthetics is weak.
It means the market is becoming less forgiving.
The practices that usually hold up best in periods like this are not the ones that panic first. They are the ones that get clearer, tighter, and more disciplined first.
They protect visibility.
They capture intent.
They retain better.
They make value easier to understand.
They increase flexibility without lowering standards.
That is what still works in medical aesthetics marketing in uncertain times.
That is the role MuseMD should play in this conversation: not fear-based software positioning, but rather system-based resilience.
MuseMD plays a vital role in this context by promoting system-based resilience rather than fear-driven software positioning.